Agreed! After that filing last night and looking over the DD here I think this has a VERY bright future! Would not be surprised with .05+ very short term.
Following statement in the filing does not look good.
"We have abandoned our pursuit of FDA clearance and marketing of any drugs or products, including LiprostinTM, the patented pharmaceutical for a controlled drug delivery system. When rights to the drug were acquired it was represented that the initial clinical trials had been successfully completed and the single remaining trial was eligible to go forward. Research disclosed the representations are untrue. Therefore, further efforts to seek clearance and market the product ceased".
News 
Market Data 
Discover 
